|
|
|
Country/Territory: | United Kingdom |
Disclosure:
(view policy)
|
Member reports the following financial or other potential conflicts of interest: [Last Modified: 20 July 2010]
Deputy Chief Scientific Officer for TauRx Therapeutics Ltd. and WisTa Laboratories Ltd.
|
|
|
View all comments by Charlie Harrington
|
Aging Process, Alzheimer Disease, Tauopathies, Polyglutamine Disorders (Huntington's, etc.), Prion Diseases, Parkinson Disease
|
Diagnosis, Neurobiology, Clinical trials, A-beta PP/A-beta, Drug screening, Animal Models, Molecular and Cell biology, Brain imaging, Neuropathology, Tau/Cytoskeleton
|
|
|
Home
